Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-08-14
2007-08-14
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S235100
Reexamination Certificate
active
10669175
ABSTRACT:
Disclosed are methods for screening that may be used to identify an inhibitor of HCV p7 protein. The methods may include incorporating an HCV p7 protein into a membrane to create an HCV p7-containing membrane that has an increased permeability relative to a membrane that does not contain HCV p7 protein. The HCV p7 protein may be contacted with a test compound, and the permeability of this HCV p7-containing membrane then may be compared to an HCV p7-containing membrane in which the HCV p7 protein has not been contacted with the test compound. The inhibitor of HCV p7 protein may be identified by observing a decrease in the permeability of the HCV p7-containing membrane in which the HCV p7 protein has been contacted with the test compound.
REFERENCES:
patent: 4246345 (1981-01-01), Kinast et al.
patent: 4266025 (1981-05-01), Kinast et al.
patent: 4405714 (1983-09-01), Kinast et al.
patent: 4806650 (1989-02-01), Schroder et al.
patent: 4861892 (1989-08-01), Fleet
patent: 4894388 (1990-01-01), Fleet
patent: 4910310 (1990-03-01), Campbell et al.
patent: 4944572 (1990-07-01), Young
patent: 4996329 (1991-02-01), Fleet et al.
patent: 5011929 (1991-04-01), Fleet et al.
patent: 5013842 (1991-05-01), Fleet et al.
patent: 5017704 (1991-05-01), Fleet et al.
patent: 5043273 (1991-08-01), Scudder et al.
patent: 5100797 (1992-03-01), Fleet et al.
patent: 5200523 (1993-04-01), Fleet
patent: 5286877 (1994-02-01), Behling et al.
patent: 5310745 (1994-05-01), Partis et al.
patent: 5580884 (1996-12-01), Platt et al.
patent: 5622972 (1997-04-01), Bryant et al.
patent: 6291657 (2001-09-01), Platt et al.
patent: 6355413 (2002-03-01), Gage et al.
patent: 2006/0252918 (2006-11-01), Rowlands et al.
patent: 445098 (1991-02-01), None
patent: WO 98/35685 (1998-08-01), None
patent: WO 99/24401 (1999-05-01), None
patent: WO 00/47198 (2000-08-01), None
patent: WO 01/10429 (2001-02-01), None
patent: WO 01/60366 (2001-08-01), None
patent: WO 2004/005333 (2004-01-01), None
Sakai et al. PNAS (2003) vol. 100, No. 20, 11646-11651.
De Francesco, R. “Biochemical and immunologic properties of the nonstructural proteins of the hepatitis C virus: implications for development of antiviral agents and vaccines” Semin. Liver Dis. 2000; 20 (1): 69-83.
Griffin, S.D.C. “A conserved basic loop in hepatitis C virus p7 protein is required for amantadine-sensitive ion channel activity.in mammalian cells but is dispensible for localization in mitochondria” Journ. Gen. Virol. 2004; 85: 451-461.
Carrere-Kremer, S. “Subcellular localization and Topology of the p7 Polypeptide of Hepatitis C Virus” J. Virol. Apr. 2002; 76 (8): 3720-3730.
Griffin, S.D.C. “The protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine” FEBS Letters 2003; 535: 34-38.
Rokitskaya, Antonenko, Kotova, Anastasiadis and Separovic, 2000, Biochemistry, 39, 13053-13058. Effect of Avidin on Channel Kinetics of Biotinylated Gramicidin.
Swartz and MacKinnon, 1995, Neuron, 4, 941-9. An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula.
Smith JP, 1997, Dig Dis Sci, 42(8), 1681-7. Treatment of chronic hepatitis C with amantadine.
Griffin et al (2003) FEBS Letters. 535: 34-38.
Di Bisceglie, Adrian M., “Hepatitis C and Hepatocellular Carcinoma,” Hepatology vol. 26, No. 3, Suppl. 1, Sep. 1997, pp. 345-350.
Egger et al., “Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex”,Journal of Virology, American Society for Microbiology, vol. 76, No. 12, Jun. 2002, pp. 5974-5984.
Annex to Form PCT/ISA/206, Communication Relating To The Results Of The Partial International Search, date of mailing Sep. 13, 2004, 2 pages.
Bergeron et al., “Calnexin: a membrane-bound chaperone of the endoplasmic reticulum,” TIBS Mar. 19, 1994, Elsevier Scient Ltd. 0968-0004/94 pp. 124-128.
Branza-Nichita et al., “Antiviral of N-Butyledeoxynojirimycin against Bovine Viral Diarrhea Virus Coorelates with Misfolding of E2 Envelope Proteins and Impairment of Their Association into E1-E2 Heterodimers,” (2001) J. Virol. 75(8), pp. 3527-36.
Carrere-Kremer et al., Subcellular Localization and Topology of the p7 Polypeptide of Hepatitis C Virus, (2002) J. Virol. 76(8), pp. 3720-30.
Choukhi et al., Involvement of Endoplasmic Reticulum Chaperones in the Folding of Hepatitus C Virus Glycoproteins, (1998) J. Virol., 72(5), pp. 3851-8.
Courageot et al., “α-Glucosidase Inhibitors Reduce Dengue Virus Production by Affecting the Initial Steps of Virion Morphogenesis in the Endoplasmic Reticulum,” (2000) J. Virol., 74(1): pp. 564-72.
Duff et al., “The Transmembrane Domain of Influenza A M2 Protein Forms Amantadine-Sensitive Proton Channels in Planar Lipid Bilayers,” Virology 190, pp. 485-489 (1992) 0042-6822/92 Copyright 1992 by Academic Press, Inc.
Durantel et al., “Study of the Mechanism of Antiviral Action of Iminosugar Derivatives against Bovine Viral Diarrhea Virus,” (2001) J. Virol. 75(19): pp. 8987-98.
Dwek, et al., “Targeting Glycosylation as a Therapeutic Approach,” Nature Reviews/Drug Discovery, vol. 1 Jan. 2002, pp. 65-75. Glycobiology Institute, Dept. of Biochemistry, University of Oxford, Oxford OX1 3QU, UK.
Fischer et al., “Amantadine blocks channel activity of the transmembrane segment of the NB protein from influenza B,” Eur. Biophys J. (2001) 3-: pp. 416-420, DOI 10.1007/s00240100157.
Griffin et al., “The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine,” FEBS Letters 535 (2003) pp. 34-38, Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
Harada et al., “E2-p7 Region of the Bovine Viral Diarrhea Virus Polyprotein: Processing and Functional Studies,” (2000) J. Virol. 74(20): pp. 9498-506.
Hay et al., “The molecular basis of the specific anti-influenza action of amantadine,” EMBO Journal, vol. 4 No. 11 pp. 3021-3024, 1985. Oxford, England.
Lin et al., “Processing in the Hepatitis C Virus E2-NS2 Region: Identification of p7 and Two Distinct E2-Specific Products with Different C Termini,” (1994) J. Virol. 68(8): pp. 5063-73.
Lohmann et al., “Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line,” (1999) Science, 285(5424) pp. 110-3.
Mehta et al., “α-Glucosidase inhibitors as potential broad based anti-viral agents,” FEBS Lett. Jun. 1998 23;430(1-2): pp. 17-22.
Mizushima et al., “Two Hepatitis C Virus Glycoprotein E2 Products with Different C Termini,” (1994) J. Virol. 68(10): pp. 6215-22.
Montal et al., “Formation of Bimolecular Membranes from Lipid Monolayers and a Study of Their Electrical Properties,” Proc. Nat. Acad. Sci. USA 69 (1972) pp. 3561-3566.
Pavlovic et al., “The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives,” PNAS May 13, 2003; 100(10): pp. 6104-8.
Peterson et al., “Transient, Lectin-like Association of Calreticulin with Folding Intermediates of Cellular and Viral Glycoproteins,” Molecular Biology of the Cell, vol. 6, pp. 1173-1184, Sep. 1995 by The American Society for Cell Biology.
Pietschmann et al., “Characterization of Cell Lines Carrying Self-Replicating Hepatitis C Virus RNAs,” (2001) J. Virol. 75(3): pp. 1252-64.
Reed et al., “Overview of Hepatitis C Virus Genome Structure, Polyprotein Processing, and Protein Properties,” Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, pp. 55-84.
Sunstrom, et al., “Ion Channels Formed by NB, an Influenza B Virus Protein,” J. Membrane Biol. 150, pp. 127-132 (1996).
Wu et al., “Antiviral Effects of an Iminosugar Derivative on Flavivirus Infections,” (2002) J. Virol., 76(8): pp. 3596-604.
Xu et al., “Sy
Frs Raymond Allen Dwek
Zitzmann Nicole
Campell Bruce R.
Foley & Lardner LLP
Horning Michelle
The Chancellor, Masters and Scholars of the University of Oxford
LandOfFree
Methods for identifying iminosugar derivatives that inhibit... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for identifying iminosugar derivatives that inhibit..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for identifying iminosugar derivatives that inhibit... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3863277